NICE has recommended wider access to continuous glucose monitoring (CGM) for adults with type 2 diabetes, particularly those receiving insulin therapy, in its 2022 guidance. The ...
NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.
A new nationwide analysis shows very early childhood Type 2 diabetes (T2D) is still uncommon but linked with where children ...
Many people with type 2 diabetes don’t identify as being disabled, but the condition is a protected disability under federal law. You have certain protections at work and in public places if you live ...
Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...
Everyday Health on MSN
Managing type 2 diabetes when you have early-stage Alzheimer's
Learn to manage type 2 diabetes while navigating early-stage Alzheimer's with expert advice on symptoms, simplified routines, and home safety strategies.
Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...
A recent study has found that eating higher levels of red meat is associated with an increased risk of developing type 2 ...
The global type 2 diabetes market size surpassed USD 40.09 billion in 2025 and is projected to reach approximately USD 79.25 ...
Diabetes affects every part of the body, causing symptoms like fatigue, weight gain, mood changes, and neuropathic pain, among others. These symptoms are not unique to diabetes: They are also common ...
People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.
Type 2 diabetes is not reversible, but it can go into remission, meaning your blood sugar levels return to normal without medication for at least three months. Some people can achieve this by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results